secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aspira Women's Health Inc. (AWHL)
CIK:        0000926617
Form:       8-K
Filed at:   2024-12-16T23:59:59+00:00
Accession:  0001493152-24-050269
Event type: leadership
Sentiment:  negative
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aspira Women's Health CEO Sandford steps down; Dr. Milligan interim CEO
-----------------------------------------------------------------------

- CEO Nicole Sandford departs immediately for family health matter; remains as consultant for transition.
- President Dr. Sandra Milligan named interim CEO; nationwide search for permanent successor underway.
- Separation: $375,000 biweekly over 9 months plus $135,000 bonus upon fundraising or by Sept 30, 2025.
- Board cites Sandford's role in launching OvaWatch and securing $10M ARPA-H award for endometriosis test.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/926617/000149315224050269/0001493152-24-050269-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/926617/000149315224050269/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-050269

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer